Lysophospholipid receptors

Annual Review of Pharmacology and Toxicology

Volumn 41, Issue , 2001, Pages 507-534

  Fukushima, N ^a   Ishii, I ^a   Contos, J J A ^a   Weiner, J A ^a   Chun, J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Development; G protein coupled receptor; Lysophosphatidic acid; Nervous system; Sphingosine 1 phosphate

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LIPID; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID RECEPTOR; PHOSPHOLIPID DERIVATIVE; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

BIOSYNTHESIS; CARDIOVASCULAR SYSTEM; GENE EXPRESSION; GENOME; MOLECULAR CLONING; NERVOUS SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEQUENCE TAGGED SITE; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; LYSOPHOSPHOLIPIDS; RECEPTORS, CELL SURFACE;

EID: 0035028449     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.41.1.507     Document Type: Review

References (126)

1. Pharmacologically active acidic phospholipids and glycolipids
2. 32P-labelling of phosphatidic acid
3. Phosphatidic acid that accumulates in platelet-derived growth factor-stimulated Balb/c 3T3 cells is a potential mitogenic signal
4. Mepacrine (quinacrine) inhibition of thrombin-induced platelet responses can be overcome by lysophosphatidic acid
5. Sphingolipid metabolites: Members of a new class of lipid second messengers
6. Platelet aggregating activity of lysophosphatidic acids is not related to their calcium ionophore properties
7. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens
8. Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins
9. Lysophosphatidic acid: G-protein signalling and cellular responses
10. Bioactive lysophospholipids and their G protein-coupled receptors
11. Sphingosine-1-phosphate, a metabolite of sphingosine, increases phosphatidic acid levels by phospholipase D activation
12. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation
13. A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes
14. A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils
15. Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: Action through a specific cell surface receptor
16. Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid
17. Sphingosine 1-phosphate regulates melanoma cell motility through a receptor-coupled extracellular action and in a pertussis toxin-insensitive manner
18. 2+ system in FRTL-5 thyroid cells: Possible involvement of guanosine triphosphate-binding proteins in the lipid signaling
19. Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid
20. Identification and characterization of a lysophosphatidic acid receptor
21. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex
22. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lyso-phospholipids (LPs)
23. Lysophospholipid receptors: Implications for neural signaling
24. Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1
25. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1
26. Neurobiology of receptor-mediated lysophospholipid signaling, from the first lysophospholipid receptor to roles in the nervous system function and development
27. 2+ signaling pathway
28. Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6
29. The immediate-early gene product MAD-3/EDG-3/IkappaB alpha is an endogenous modulator of fibroblast growth factor-1 (FGF-1) dependent human endothelial cell growth
30. Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes
31. Mammalian PSP24s (α and β isoforms) are not responsive to lysophosphatidic acid in mammalian expression systems
32. Identification of human OGR1, a novel G protein-coupled receptor that maps to chromosome 14
33. Sphingosylphosphorylcholine is a ligand for ovarian cancer Gprotein-coupled receptor 1
34. Sphingosine-1-phosphate: Extracellular mediator or intracellular second messenger?
35. Molecular diversity of sphingolipid signalling
36. Neural expression of a novel alternatively spliced and polyadenylated Gs alpha transcript
37. Clonal cell lines produced by infection of neocortical neuroblasts using multiple oncogenes transduced by retroviruses
38. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors
39. A1/vzg-1/Gpcr26
40. Cloning, characterization, and chromosomal localization of rec1.3, a member of the G-protein-coupled receptor family highly expressed in brain
41. Vacillans, a neurological mutant in the house mouse linked to brown
42. Characterization of a receptor subtype-selective lysophosphatidic acid mimetic
43. A rat G protein-coupled receptor selectively expressed in myelin-forming cells
44. A1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid
45. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8
46. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate
47. Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate
48. Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid
49. A3/EDG-7 in neuronal cell lines using a retrovirus expression system
50. Activation of Gil by lysophosphatidic acid receptor without ligand in the baculovirus expression system
51. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization
52. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid
53. A1/edg-2 is expressed by mature oligodendrocytes during myelination in the posmatal murine brain
54. Lysophosphatidic acid receptors
55. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner
56. A2/Edg4, and identification of a frameshift mutation in a previously characterized cDNA
57. Characterization of a novel sub-type of human G protein-coupled receptor for lysophosphatidic acid
58. Embryonic vertebrate central nervous system: Revised terminology
59. Mitosis in the neural tube
60. Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex
61. Programmed cell death is a universal feature of embryonic and postnatal neuroproliferative regions throughout the central nervous system
62. Scanning and transmission electron microscope studies of interkinetic nuclear migration in the cerebral vesicles of the rat
63. Regulation of neurogenesis by growth factors and neurotransmitters
64. Lysophosphatidic acid (LPA) stimulates neurotransmitter-like conductance changes that precede GABA and L-glutamate in early, presumptive cortical neuroblasts
65. GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis
66. A1 lysophosphatidicacid receptor gene in normal suckling behavior
67. Lysophosphatidic acid (LPA) is a novel extracellular regulator of cortical neuroblast morphology
68. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
69. Slit proteins: Key regulators of axon guidance, axonal branching, and cell migration
70. DCC and netrins
71. Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho
72. 2+ signaling and Rho
73. Effects of lysophosphatidic acid on primary cultured chick neurons
74. Rac1 mediates collapsin-1-induced growth cone collapse
75. Synergism among lysophosphatidic acid, beta1A integrins, and epidermal growth factor or platelet-derived growth factor in mediation of cell migration
76. Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells
77. Cell death in the Schwann cell lineage and its regulation by neuregulin
78. Serum contains inducers and repressors of oligodendrocyte differentiation
79. The bioactive phospholipid lysophosphatidic acid is released from activated platelets
80. Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for survival
81. Vzg-1/lysophosphatidic acid-receptor involved in peripheral pain transmission
82. Invasion of T-lymphoma cells: Cooperation between Rho family GTPases and lysophospholipid receptor signaling
83. Involvement of small GTPases Rho and Rac in the invasion of rat ascites hepatoma cells
84. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D
85. Malignant effusions contain lysophosphatidic acid (LPA)-like activity
86. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers
87. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer
88. Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes: A paracrine signal for preadipocyte growth
89. Lysophosphatidates bound to serum albumin activate membrane currents. In Xenopus oocytes and neurite retraction in PC 12 pheochromocytoma cells
90. Lysophosphatidic acid mediates the rapid activation of platelets and endothehal cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions
91. Lysophosphatidic acid as a phospholipid mediator: Pathways of synthesis
92. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells
93. Metalion stimulation and inhibition of lysophospholipase D which generates bioactive lysophosphatidic acid in rat plasma
94. Mammalian lipid phosphate phosphohydrolases
95. Mammalian lysophospholipases
96. Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid
97. The mouse gene for the inducible G-protein-coupled receptor edg-1
98. Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells
99. 2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition
100. Dual actions of sphingosine-1-phosphate: Extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival
101. (12) families of heterotrimeric G proteins
102. Molecular cloning of a novel putative G protein-coupled receptor expressed in the cardiovascular system
103. Cloning and characterization of a putative G-protein coupled receptor potentially involved in development
104. Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218
105. Transduction of intracellular calcium signals through G protein-mediated activation of phospholipase C by recombinant sphingosine 1-phosphate receptors
106. The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways
107. Embryonic expression pattern of H218, a G-protein coupled receptor homolog, suggests roles in early mammalian nervous system development
108. Molecular cloning of the novel human G protein-coupled receptor (GPCR) gene mapped on chromosome 9
109. EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16
110. Molecular cloning, tissue-specific expression, and chromosomal localization of a novel nerve growth factor-regulated G-protein-coupled receptor, nrg-1
111. EDG6, a novel G-protein-coupled receptor related to receptors for bioacrive lysophospholipids, is specifically expressed in lymphoid tissue
112. Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5
113. Prostanoid receptors: Structures, properties, and functions
114. Activation of a high affinity Gi protein-coupled plasma membrane receptor by sphingosine-1-phosphate
115. + current in guinea-pig atrial myocytes by sphingosine-1-phosphate
116. Evidence for edg-3 receptor-mediated activation of I (K, Ach) by sphingosine-1-phosphate in human atrial cardiomyocytes
117. Calcium signalling by G protein-coupled sphingolipid receptors in bovine aortic endothelial cells
118. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: Spatial and temporal modulation of PDGF chemotactic signal transduction
119. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate
120. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation
121. Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells
122. Sphingolipid receptor signaling and function in human bladder carcinoma cells: Inhibition of LPA- but enhancement of thrombin-stimulated cell motility
123. Sphingosine-1-phosphate: A platelet-activating sphingolipid released from agonist-stimulated human platelets
124. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum
125. Evidence that lipoproteins are cartiers of bioactive factors